References
- 1. Simpson, I.W. (1982). Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterol. 82, 171-178.
- 2. Stanley, P. (1989). Budd-Chiari syndrome. Radiol. 170, 625-627. http://dx.doi.org/10.1148/radiology.170.3.2644657 PMid:2644657
- 3. Nakamura T., Nakamura S., Aikawa T., Suziki, O., Onodera, A., Karoji, N. (1968). Obstruction of the inferior vena cava in the hepatic portion and the hepatic veins. Angiol. 19(8): 479-500. http://dx.doi.org/10.1177/000331976801900805
- 4. Amesur, N.B., Zajko, A.B. (2006). Interventional radiology in liver transplantation. Liver Transpl Surg. 12, 330-351. http://dx.doi.org/10.1002/lt.20731 PMid:16498660
- 5. Zhang, X., Qing-Le, L. (2007). Etiology, treatment, and classification of Budd-Chiari syndrome. Chin Med J. 120, 159-161. http://dx.doi.org/10.3901/JME.2007.04.159
- 6. Durgut, R., Ataseven, V.S., Sagkan-Ozturk, A., Ozturk, O.H. (2013). Evaluation of total oxidative stress and total antioxidant status in cows with natural bovine herpesvirus-1 infection. J Anim Sci. 91, 1–5. http://dx.doi.org/10.2527/jas.2012-5516 PMid:23798525
- 7. Erel, O. (2004). A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 37, 112-119. http://dx.doi.org/10.1016/j.clinbiochem.2003.10.014 PMid:14725941
- 8. Erel, O. (2005). A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 38, 1103-1111. http://dx.doi.org/10.1016/j.clinbiochem.2005.08.008 PMid:16214125
- 9. Schrope, D.S. (2010). Hepatic vein stenosis (Budd-Chiari syndrome) as a cause of ascites in a cat. J Vet Cardiol. 12, 197-202. http://dx.doi.org/10.1016/j.jvc.2010.05.002 PMid:21078565
- 10. Okuda, K., Kage, M., Shrestha, S.M. (1998). Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 28, 1191-1198. http://dx.doi.org/10.1002/hep.510280505 PMid:9794901
- 11. Okuda, K. (2001). Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol. 16, 1179-1183. http://dx.doi.org/10.1046/j.1440-1746.2001.02577.x PMid:11903732
- 12. Takayasu, K., Muramatsu, Y., Moriyama, N., Wakao, F., Makuuchi, M., Takayama, T., Kosuge, T., Okazaki, N., Yamada, R. (1994). Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma: a report of four cases. Am J Gastroenterol. 88, 249-253.
- 13. Horoz, M., Bolukbas, C., Bolukbas, F.F., Aslan, M., Koylu, A.O., Selek, S., Erel, O. (2006). Oxidative stres in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis. 6, 114. http://dx.doi.org/10.1186/1471-2334-6-114 PMid:16842626 PMCid:PMC1543638
- 14. Karaagac, L., Koruk, S.T., Koruk, I., Aksoy, N. (2011). Decreasing oxidative stress in response to treatment in patients with brucellosis: could it be used to monitor treatment. Int J Infect Dis. 15(5): 346-349. http://dx.doi.org/10.1016/j.ijid.2011.01.009 PMid:21376649
- 15. Karsen, H., Sunnetcioglu, M., Ceylan, R.M. (2011). Evaluation of oxidative status in patients with Fasciola hepatica infection. Afr Health Sci. 11(1): 14-18. http://dx.doi.org/10.4314/ahs.v11i3.70064
- 16. Maden, M., Ozturk, S.A., Bulbul, A., Avci, G., Yazar, E. (2012). Acute phase proteins, oxidative stress and enzyme activities of blood serum and peritoneal fluid in abomasal displacement cases. J Vet Intern Med. 26, 1470–1475. http://dx.doi.org/10.1111/j.1939-1676.2012.01018.x PMid:23113812
- 17. Braun, U. (2008). Clinical findings and diagnosis of thrombosis of the caudal vena cava in cattle. The Vet J. 175, 118–125. http://dx.doi.org/10.1016/j.tvjl.2006.11.013 PMid:17239635
- 18. Fisher, N.C., Mccafferty, I., Dolapci, M., Wali, M., Buckels, J.A.C., Olliff, S.P., Elias, E. (1999). Managing Budd-Chiari syndrome: a restrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 44, 568-574. http://dx.doi.org/10.1136/gut.44.4.568 PMid:10075967 PMCid:PMC1727471
- 19. Lin, X.H., Jiao, L.L., Xu, G.B., Tian, G.S. (2006). Significance of serum carnitine in patients with liver diseases. Zhonghua Gan Zang Bing ZaZhi, 14(5): 367-369.
- 20. Malaguarnera, M., Vacante, M., Giordano, M., Motta, M., Bertino, G., Pennisi, M., Neri, S., Malaguernera, M., Li Volti, G., Galvano, F. (2011). L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol. 17(39): 4414-4420. http://dx.doi.org/10.3748/wjg.v17.i39.4414 PMid:22110268 PMCid:PMC3218156
- 21. Cekin, AH., Gur, G., Turkoglu, S., Aldemir, D., Yılmaz, U., Gursoy, M., Taskoparan, M., Boyacıoğlu, S. (2013). The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats. Turk J Gastroenterol. 24 (1): 51-56. PMid:23794344